Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.070
+0.020 (1.90%)
Nov 20, 2024, 4:00 PM EST - Market closed
Achilles Therapeutics Market Cap
Achilles Therapeutics has a market cap or net worth of $43.96 million as of November 21, 2024. Its market cap has increased by 19.57% in one year.
Market Cap
43.96M
Enterprise Value
-38.47M
1-Year Change
19.57%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since the IPO on March 31, 2021, Achilles Therapeutics's market cap has decreased from $731.19M to $43.96M, a decrease of -93.99%. That is a compound annual growth rate of -53.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 43.14M | 18.99% |
| Dec 29, 2023 | 36.26M | -1.60% |
| Dec 30, 2022 | 36.84M | -81.89% |
| Dec 31, 2021 | 203.42M | -72.18% |
| Mar 31, 2021 | 731.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 44.46M |
| Actinium Pharmaceuticals | 44.30M |
| Gain Therapeutics | 43.92M |
| Fortress Biotech | 43.83M |
| Daxor | 43.51M |
| OncoCyte | 42.93M |
| Reviva Pharmaceuticals Holdings | 42.14M |
| Omega Therapeutics | 41.92M |